Enliven Therapeutics shares owned by BML Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by BML Capital Management
from 13F filings
Historical chart of BML Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by BML Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $881k | 50k | 17.59 |
| 2023-12-31 | $692k | 50k | 13.84 |
| 2023-09-30 | $683k | 50k | 13.66 |
| 2023-06-30 | $1.5M | 74k | 20.41 |
| 2023-03-31 | $4.6M | 212k | 21.90 |